Product image of Mometasone Teva (Mometasone Furoate) supplied by GNH India

Mometasone Teva

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometasone Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Teva, is a corticosteroid presented as a nasal spray for intranasal use. It treats allergic rhinitis and reduces nasal inflammation in adults and children.

GNH India supplies Mometasone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance, and reliable logistics for global healthcare providers, with a focus on timely delivery and adherence to Good Distribution Practice standards, our network spans Europe, Asia, Africa and the Americas, enabling consistent product availability across diverse markets.

Manufacturer / TM Owner

Teva Pharma Belgium N.V./S.A

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate nasal spray is a potent intranasal corticosteroid that targets inflammatory pathways in the nasal mucosa, offering effective symptom control for various allergic and non‑allergic nasal conditions.

  • Allergic rhinitis (seasonal): decreases nasal congestion, sneezing, itching and rhinorrhea during pollen seasons.
  • Allergic rhinitis (perennial): controls chronic nasal inflammation, reducing daily symptoms such as blockage and watery discharge.
  • Non‑allergic rhinitis: alleviates nasal irritation and congestion when triggered by irritants or hormonal changes.
  • Seasonal allergic rhinitis: provides rapid relief of acute symptoms within days of treatment initiation.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the production of pro‑inflammatory cytokines, reduces vascular permeability, and limits edema of the nasal mucosa, leading to decreased nasal obstruction and irritation.

Side Effects

Mometasone Teva may cause local and systemic adverse reactions. Patients should be aware of the following potential effects.

Common Side Effects

  • Nasal irritation or burning sensation
  • Headache
  • Epistaxis (nosebleed)
  • Throat irritation or dryness
  • Cough
  • Altered taste perception

Serious or Rare Side Effects

  • Nasal septal perforation
  • Severe allergic reaction (anaphylaxis)
  • Vision changes or cataract formation
  • Adrenal suppression with prolonged use
  • Opportunistic fungal infection of the nasal passages
  • Persistent or worsening nasal congestion despite therapy

Precautions & Warnings

Before using Mometasone Teva, consider the following precautions.

  • Pregnancy: consult a healthcare professional to weigh potential benefits against risks.
  • Breastfeeding: discuss possible effects on the infant with a physician.
  • Recent nasal surgery or trauma: postpone use until the nasal mucosa has healed.
  • Long‑term therapy: monitor for signs of adrenal suppression or systemic corticosteroid effects.
  • Pediatric use: follow pediatric dosing recommendations and monitor growth.
  • Store at room temperature: keep in the original container, protect from moisture and direct heat.

Avoid Interactions

Mometasone Teva can interact with other medications; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid)

  • Systemic corticosteroids: may increase the risk of systemic corticosteroid side effects.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): could raise local drug exposure.
  • Live vaccines: nasal corticosteroids may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Nasal decongestants: may increase local irritation when used together.
  • Antifungal nasal sprays: potential additive irritation of the nasal mucosa.
  • Immunosuppressants: monitor for heightened infection risk during combined therapy.

Frequently Asked Questions

Mometasone Teva is an intranasal corticosteroid indicated for the treatment of allergic rhinitis, including both seasonal and perennial forms. It helps relieve nasal congestion, sneezing, itching, and runny nose by reducing inflammation of the nasal passages.

Mometasone furoate acts as an agonist at glucocorticoid receptors in nasal mucosal cells. By binding these receptors, it alters gene transcription, suppressing the release of inflammatory cytokines and mediators, which decreases swelling and mucus production in the nasal cavity.

The specific dosing regimen for Mometasone Teva is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and response to therapy. Patients should follow the prescriber’s instructions and the product label.

Safety data for Mometasone Teva in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing it to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone Teva offers a high‑potency corticosteroid option with once‑daily dosing for many patients. Compared with agents such as fluticasone or budesonide, it provides similar anti‑inflammatory efficacy but may differ in onset of action, systemic absorption and individual tolerability, which the prescriber will consider.

Store the nasal spray at room temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme heat. Keep the device upright and avoid freezing.

The spray is used intranasally. After gently shaking the bottle, insert the tip into one nostril, close the opposite nostril, and press down to deliver the prescribed number of sprays. Repeat in the other nostril if directed, and avoid blowing the nose for several minutes after use.

Serious adverse events, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, vision changes, adrenal suppression with prolonged high‑dose use, and opportunistic fungal infections of the nasal passages. Patients should seek medical attention if any of these occur.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid the product. It is also contraindicated in patients with active untreated nasal infections, recent nasal surgery, or severe nasal trauma until healed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT